Chemotherapy News and Research

Latest Chemotherapy News and Research

New weapon against cancer: "DNA warhead" targets mutant protein in tumor cells

New weapon against cancer: "DNA warhead" targets mutant protein in tumor cells

Novel method predicts cancer cell behaviors using nano informatics and machine learning

Novel method predicts cancer cell behaviors using nano informatics and machine learning

New type of immunotherapy shows promising preclinical results against osteosarcoma

New type of immunotherapy shows promising preclinical results against osteosarcoma

New ultrasound method reveals minute vascular structures using contrast agents

New ultrasound method reveals minute vascular structures using contrast agents

Proline-based nano cages offer targeted drug delivery, limit side effects of chemotherapy

Proline-based nano cages offer targeted drug delivery, limit side effects of chemotherapy

MUSC researchers unravel the mystery of cancer recurrence

MUSC researchers unravel the mystery of cancer recurrence

Osaka University to pioneer world-first clinical trial for refractory prostate cancer with alpha-ray therapy

Osaka University to pioneer world-first clinical trial for refractory prostate cancer with alpha-ray therapy

AI-based body composition analysis predicts lung cancer treatment outcomes

AI-based body composition analysis predicts lung cancer treatment outcomes

Immunotherapy-chemotherapy combo boosts survival for patients with metastatic colorectal cancer

Immunotherapy-chemotherapy combo boosts survival for patients with metastatic colorectal cancer

Biological similarities found between "chemo brain" and brain fog after COVID-19

Biological similarities found between "chemo brain" and brain fog after COVID-19

Tailored antibody-drug conjugate offers hope for aggressive breast cancer

Tailored antibody-drug conjugate offers hope for aggressive breast cancer

Donepezil fails to enhance cognitive abilities in breast cancer survivors: Phase III trial results

Donepezil fails to enhance cognitive abilities in breast cancer survivors: Phase III trial results

Study identifies PI3K-beta as key target in overcoming chemotherapy resistance in glioblastoma

Study identifies PI3K-beta as key target in overcoming chemotherapy resistance in glioblastoma

Disabling survival pathways could be a promising strategy for brain tumor treatment

Disabling survival pathways could be a promising strategy for brain tumor treatment

Comprehensive cost and utilization of commercial CAR-T therapy in pediatric B-ALL patients

Comprehensive cost and utilization of commercial CAR-T therapy in pediatric B-ALL patients

Perioperative immunotherapy improves event-free survival in patients with resectable NSCLC

Perioperative immunotherapy improves event-free survival in patients with resectable NSCLC

Oncotype DX Breast Recurrence Score test recommended by NICE for lymph node-positive breast cancer patients

Oncotype DX Breast Recurrence Score test recommended by NICE for lymph node-positive breast cancer patients

St. Jude researchers unveil mechanisms to block PXR and enhance drug potency

St. Jude researchers unveil mechanisms to block PXR and enhance drug potency

Study reveals unintended consequences of antibiotic choice in sepsis treatment

Study reveals unintended consequences of antibiotic choice in sepsis treatment

Combined exercise and diet interventions show potential in improving ovarian cancer patients' outcomes

Combined exercise and diet interventions show potential in improving ovarian cancer patients' outcomes

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.